DNA interactions of bifunctional dinuclear platinum(II) antitumor agents

European Journal of Biochemistry

Volumn 246, Issue 2, 1997, Pages 508-517

  Žaludová, Renata ^a   Žákovská, Alena ^a   Kašpárková, Jana ^a   Balcarová, Zdenka ^a   Kleinwächter, Vladimír ^a   Vrána, Oldřich ^a   Farrell, Nicholas ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Anticancer effect; Cross link; Dinuclear complex; DNA; Platinum drug

Indexed keywords

CISPLATIN; PLATINUM DERIVATIVE; TRANSPLATIN;

ABSORPTION SPECTROPHOTOMETRY; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DIFFERENTIAL PULSE POLAROGRAPHY; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; IN VITRO STUDY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030968827     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00508.x     Document Type: Article

References (45)

1. 195Pt NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA, J. Am. Chem. Soc. 112, 6860-6871.
2. Barry, M. A., Behnke, C. A. & Eastman, A. (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia, Biochem. Pharmacol. 40, 2353-2362.
3. 2 forms a unique macrochelate intrastrand cross-link with d(GpG), J. Chem. Soc. Chem. Commun., 1002-1003.
4. Blommmaert, F. A., van Dijk-Knijnenburg, H. C. M., Dijt, F. J., den Engelse, L., Baan, R. A., Berends, F. & Fichtinger-Schepman, A. M. J. (1995) Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Biochemistry 34, 8474-8480.
5. Brabec, V. & Leng, M. (1993) DNA interstand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues, Proc. Natl Acad. Sci. USA 90, 5345-5349.
6. Brabec, V. & Palećek, E. (1970) The influence of salts and pH on polarographic currents produced by denatured DNA, Biophysik 6, 290-300.
7. Brabec, V., Kleinwächter, V., Butour, J.-L. & Johnson, N. (1990) Biophysical studies of the modification of DNA by antitumour platinum coordination complexes, Biophys. Chem. 35, 129-141.
8. Brabec, V., Vrána, O., Kiseleva, V. I. & Poverenny A. M. (1991) PoIyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments, Eur. J. Biochem. 201, 723-730.
9. Brabec, V., Reedijk, J. & Leng, M. (1992) Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding, Biochemistry 31, 12397-12402.
10. Brabec, V., Boudný, V. & Balcarová, Z. (1994) Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation, Biochemistry 32, 1316-1322.
11. Corda, Y., Job, C., Anin, M-F., Leng, M. & Job, D. (1991) Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II), Biochemistry 30, 222-230.
12. Corda, Y., Anin, M-F., Leng, M. & Job, D. (1992) RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II), Biochemistry 31, 1904-1908.
13. Corda, Y. Job, C., Anin, M.-F., Leng, M. & Job, D. (1993) Spectrum of DNA-platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases, Biochemistry 32, 8582-8588.
14. Drobnik, J. (1983) Antitumor activity of platinum complexes, Cancer Chemother. Pharmacol. 10, 145-149.
15. Eastman, A. (1987) The formation, isolation, and characterization of DNA adducts produced by anticancer platinum complexes, Pharmacol. Ther. 34, 155-166.
16. Farrell, N., Qu, Y. Feng, L. & van Houten, B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues, Biochemistry 29, 9522-9531.
17. Farrell, N. (1991) Structurally novel platinum antitumor compounds, in Platinum and other metal coordination compounds in cancer chemotherapy (Howell, S. B., ed.) pp. 81-91, Plenum Press, New York.
18. Farrell, N., Appleton, T. G., Qu, Y, Roberts, J. D., Soares Fontes, A. P., Skov, K. A., Wu, P. & Zou, Y. (1995) Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA, Biochemistry 34, 15480-15486.
19. Fichtinger-Schepman, A. M. J., van der Veer, J. L., den Hartog, J. H. J., Lohman, P. H. M. & Reedijk, J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation, Biochemistry 24, 707-713.
20. Harrap, K. R. (1985) Preclinical studies identifying carboplatin as a viable cisplatin alternative. Cancer Treat. Rev. 12 (Suppl. A), 21-33.
21. Hoeschele, J. D., Kraker, A. J., Qu, Y., Van Houten, B. & Farrell, N. (1990) Bis(platinum) complexes, chemistry, antitumor activity and DNA-binding, in Molecular basis of specificity in nucleic acid-drug interactions (Pullman, B. & Jortner, J., eds) pp. 301-321, Kluwer Academic Press, Dordrecht.
22. Ivanov, V. I., Minchenkova, L., Minyat, E. E., Frank-Kamenetskii, M. D. & Schyolkina, A. K. (1974) The B-to-A transition of DNA in solution, J. Mol. Biol. 87, 817-833.
23. Johnson, N. P., Butour, J.-L., Villani, G., Wimmer, F. L., Defais, M., Pierson, V. & Brabec, V. (1989) Metal antitumour compounds: the mechanism of action of platinum complexes, Prog. Clin. Biochem. Med. 10, 1-24.
24. Kane, S. A. & Lippard, S. J. (1996) Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Biochemistry 35, 2180-2188.
25. Kašpárková, J., Mellish, K. J., Qu, Y., Brabec, V. & Farrell, N. (1996) Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies, Biochemistry 35, 16705-16713.
26. Keck, M. & Lippard, S. J. (1992) Unwinding of supercoiled DNA by platinum-ethidiurn and related complexes, J. Am. Chem. Soc. 114, 3386-3390.
27. Kim, S. D., Vrána, O., Kleinwächter, V., Niki, K. & Brabec, V. (1990) Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA, Anal. Lett. 23, 1505-1518.
28. Lemaire, M.-A., Schwartz, A., Rahmouni, A. R. & Leng, M. (1991) Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum(II) and DNA. Proc. Natl Acad. Sci. USA 88, 1982-1985.
29. Leng, M. & Brabec, V. (1994) DNA adducts of cisplatin, transplatin and platinum intercalating drugs. IARC Sci. Publ. 125, 339-348.
30. Lepre, C. A. & Lippard, S. J. (1990) Interaction of platinum antitumor compounds with DNA, Nucleic Acids Mol. Biol. 4, 9-38.
31. Lippard, S. J., Ushay, H. M., Merkel, C. M. & Poirier, M. C. (1983) Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid, Biochemistry 22, 5165-5168.
32. Loehrer, P. J. & Einhorn, L. H. (1984) Cisplatin, Ann. Intern. Med. 100, 704-713.
33. Nováková, O., Vrána, O., Kiseleva, V. I. & Brabec, V. (1995) DNA interactions of antitumor platinum(IV) complexes, Eur. J. Biochem. 228, 616-624.
34. Ormerod, M. G., ONeill, C., Robertson, D., Kelland, L. R. & Harrap, K. R. (1996) cis-Diamminedichloroplatinum(II) induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol. 37, 463-471.
35. Qu, Y., Bloemink, M. J., Reedijk, J., Hambley, T. W. & Farrell, N. (1996) Dinuclear platinum complexes form a novel intrastrand adduct with d(GpG), an anti-syn conformation of the macrochelate as observed by NMR and molecular modeling, J. Am. Chem. Soc. 118, 9307-9313.
36. Reedijk, J. (1992) The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds, Inorg. Chim. Acta 198-200, 873-881.
37. Sinden, R. R. (1994) DNA structure and function, Academic Press, San Diego.
38. Vorlíčková, M. (1995) Conformational transitions of alternating purine-pyrimidine DNAs in perchlorate ethanol solutions, Biophys. J. 69, 2033-2043.
39. Vrána, O., Brabec, V. & Kleinwächter, V. (1986) Polarographic studies on the conformation of some platinum complexes: relation to antitumour activity, Anti-Cancer Drug Des. 1, 95-109.
40. Vrána, O., Kiseleva, V. I., Poverenny, A. M. & Brabec, V. (1992) Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis. Eur. J. Pharmacol. 226, 5-13.
41. Wu, P. K., Qu, Y., van Houten, B. & Farrell, N. (1994) Chemical reactivity and DNA sequence specificity of formally monofunctional and bifunctional bis(platinum) complexes, J. Inorg. Biochem. 54, 207-220.
42. Wu, P., Kharatishvili, M., Qu, Y. & Farrell, N. (1996) A circular dichroism study of ethidium bromide binding to Z-DNA induced by dinuclear platinum complexes, J. Inorg. Biochem. 63, 9-18.
43. Yang, D., van Boom, S. S. G. E., Reedijk, J., van Boom, J. H., Farrell, N. & Wang, A. H.-J. (1995) A novel DNA structure induced by the anticancer bisplatinum compound cross-linked to a GpG site in DNA, Nat. Struct. Biol. 2, 577-586.
44. Zou, Y., van Houten, B. & Farrell, N. (1994) Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes, Biochemistry 33, 5404-5410.
45. Žaludová, R., Kleinwächter, V. & Brabec, V. (1996) The effect of ionic strength on melting of DNA modified by platinum(II) complexes, Biophys. Chem. 60, 135-142.